ATTENDEES


Poster and Podium Sessions

Moderated Poster Sessions
A poster session is designed to permit the author to explain and illustrate his/her concepts, techniques or research findings in a manner that will promote understanding more readily than does a "rapid fire" podium address. Authors must be present during the entire session to respond to questions from the audience. A moderator will be present to facilitate questions.

Podium Sessions
A podium session is designed to permit the author to orally present and explain the objectives, methods, results and conclusions of his/her research. Audiovisual presentations are encouraged. Authors are allotted six minutes to present followed by a four-minute discussion specifically addressing the audience's questions.

- Saturday, May 29, 2010
- Sunday, May 30, 2010
- Monday, May 31, 2010
- Tuesday, June 1, 2010
- Wednesday, June 2, 2010

Saturday, May 29, 2010

1 - 3 p.m.

  • Adrenal: Surgery/Tumors/Benign and Malignant Disease
  • General & Epidemiological Trends & Socioeconomics: Evidence-based Medicine & Outcomes
  • Trauma/Reconstruction: Trauma & Reconstructive Surgery

3:30 - 5:30 p.m.

  • Trauma/Reconstruction: Trauma & Reconstructive Surgery
  • General & Epidemiological Trends & Socioeconomics: Evidence-based Medicine & Outcomes

back to top

Sunday, May 30, 2010

8 - 10 a.m.

  • General & Epidemiological Trends & Socioeconomics: Evidence-based Medicine & Outcomes
  • Kidney Cancer: Basic Research
  • Prostate Cancer: Basic Research
  • Prostate Cancer: Epidemiology and Natural History
  • Prostate Cancer: Staging
  • Stem Cell Research
  • Urothelial Cancer: Natural History & Pathophysiology/Markers

10:30 a.m. - 12:30 p.m.

  • Urothelial Cancer: Medical & Surgical Therapy
  • Prostate Cancer: Staging
  • Prostate Cancer: Epidemiology and Natural History
  • Pediatrics: Basic Research
  • Prostate Cancer: Localized
  • Prostate Cancer: Basic Research
  • Kidney Cancer: Basic Research
  • General & Epidemiological Trends & Socioeconomics: Quality of Life
  • Bladder and Urethra: Anatomy, Physiology and Pharmacology

1 - 3 p.m.

  • Bladder and Urethra: Anatomy, Physiology and Pharmacology
  • General & Epidemiological Trends & Socioeconomics: Practice Patterns, Cost Effectiveness
  • Kidney Cancer: Basic Research
  • Prostate Cancer: Basic Research
  • Pediatrics: Congenital Anomalies - Kidney & Ureter
  • Prostate Cancer: Localized
  • Prostate Cancer: Staging
  • Urothelial Cancer: Upper Tract Tumors

3:30 - 5:30 p.m.

  • Prostate Cancer: Advanced
  • Prostate Cancer: Localized
  • Pediatrics: Congenital Anomalies - Lower Urinary Tract & Genitalia
  • Penis/Testis/Urethra: Benign & Malignant Disease
  • Prostate Cancer: Basic Research
  • Kidney Cancer: Evaluation and Staging
  • General & Epidemiological Trends & Socioeconomics: Practice Patterns, Cost Effectiveness

back to top

Monday, May 31, 2010

8 - 10 a.m.

  • Kidney Cancer: Evaluation and Staging
  • Infections/Infla.m.mation of the Genitourinary Tract: Kidney & Bladder
  • Prostate Cancer: Basic Research
  • Pediatrics: Bladder Dysfunction - Myelodysplasia, Voiding Dysfunction, Enuresis
  • Penis/Testis/Urethra: Benign & Malignant Disease
  • Prostate Cancer: Advanced
  • Sexual Function/Dysfunction/Andrology: Basic Research
  • Urinary Diversion: Bladder Reconstruction, Augmentation, Substitution, Diversion
  • Technology & Instruments: Robotics/Laparoscopy/Ureteroscopy

10:30 a.m. - 12:30 p.m.

  • Technology & Instruments: Robotics/Laparoscopy/Ureteroscopy
  • Urinary Diversion: Bladder Reconstruction, Augmentation, Substitution, Diversion
  • Sexual Function/Dysfunction/Andrology: Basic Research
  • Prostate Cancer: Advanced
  • Prostate Cancer: Localized
  • Penis/Testis/Urethra: Benign & Malignant Disease
  • Pediatrics: Reconstructive Surgery
  • Kidney Cancer: Localized
  • Infections/Infla.m.mation of the Genitourinary Tract: Prostate & Genitalia
  • Bladder Cancer: Basic Research

1 - 3 p.m.

  • Bladder Cancer: Basic Research
  • Infections/Infla.m.mation of the Genitourinary Tract: Interstitial Cystitis
  • Bladder Cancer: Staging
  • Kidney Cancer: Localized
  • Pediatrics: Stone Disease
  • Sexual Function/Dysfunction/Andrology: Peyronie's Disease/Surgical Therapy
  • Trauma/Reconstruction: Trauma & Reconstructive Surgery
  • Prostate Cancer: Localized
  • Technology & Instruments: Robotics/Laparoscopy/Ureteroscopy
  • Urodynamics/Incontinence/Female Urology: Neurogenic Voiding Dysfunction

3:30 - 5:30 p.m.

  • Technology & Instruments: Ureteroscopy
  • Trauma/Reconstruction: Trauma & Reconstructive Surgery
  • Sexual Function/Dysfunction/Andrology: Peyronie's Disease/Surgical Therapy
  • Sexual Function/Dysfunction/Andrology: Evaluation
  • Pediatrics: Imaging (Genital & Urinary Tract/infections and Vesicoureteral Reflux/Andrology - Cryptorchidism & Varicoceles
  • Prostate Cancer: Basic Research
  • Kidney Cancer: Localized
  • Bladder Cancer: Basic Research
  • Bladder Cancer: Detection and Screening

back to top

Tuesday, June 1, 2010

8 - 10 a.m.

  • Kidney Cancer: Localized
  • Bladder Cancer: Superficial
  • Prostate Cancer: Basic Research
  • Sexual Function/Dysfunction/Andrology: Medical and Non-Surgical Therapy
  • Stone Disease: Evaluation & Medical Management
  • Technology & Instruments: Surgical Education & Skills Assessment
  • Urodynamics/Incontinence/Female Urology: Pelvic Prolapse

10:30 a.m. - 12:30 p.m.

  • Urodynamics/Incontinence/Female Urology: Incontinence - Evaluation & Therapy
  • Urodynamics/Incontinence/Female Urology: Female Urology
  • Urodynamics/Incontinence/Female Urology: Non-Neurogenic Voiding Dysfunction
  • Stone Disease: SWL, Ureteroscopic or Percutaneous Stone Removal
  • Sexual Function/Dysfunction/Andrology: Medical and Non-Surgical Therapy
  • Prostate Cancer: Basic Research
  • Bladder Cancer: Superficial
  • Kidney Cancer: Localized
  • Benign Prostatic Hyperplasia: Basic Research

1 - 3 p.m.

  • Benign Prostatic Hyperplasia: Epidemiology and Natural History/Evaluation and Markers
  • Bladder Cancer: Invasive/Metastatic Disease
  • Kidney Cancer: Advanced
  • Prostate Cancer: Localized
  • Urodynamics/Incontinence/Female Urology: Non-Neurogenic Voiding Dysfunction
  • Stone Disease: SWL, Ureteroscopic or Percutaneous Stone Removal
  • Urodynamics/Incontinence/Female Urology: Female Urology
  • Urodynamics/Incontinence/Female Urology: Urodyna.m.ic Testing
  • Urodynamics/Incontinence/Female Urology: Incontinence - Evaluation & Therapy

3:30 - 5:30 p.m.

  • Urodynamics/Incontinence/Female Urology: Incontinence - Evaluation & Therapy
  • Stone Disease: SWL, Ureteroscopic or Percutaneous Stone Removal
  • Prostate Cancer: Localized
  • Prostate Cancer: Detection and Screening
  • Kidney Cancer: Advanced
  • Bladder Cancer: Invasive/Metastatic Disease
  • Benign Prostatic Hyperplasia: Medical and Hormonal Therapy

back to top

Wednesday, June 2, 2010

8 - 10 a.m.

  • Bladder Cancer: Invasive/Metastatic Disease
  • Infertility: Physiology, Pathophysiology, Basic Research
  • Prostate Cancer: Detection and Screening
  • Prostate Cancer: Localized
  • Stone Disease: SWL, Ureteroscopic or Percutaneous Stone Removal

10:30 a.m. - 12:30 p.m.

  • Stone Disease: Basic Research
  • Prostate Cancer: Localized
  • Prostate Cancer: Detection and Screening
  • Infertility: Therapy/Evaluation
  • Benign Prostatic Hyperplasia: Surgical Therapy and New Technology

1 - 3 p.m.

  • Benign Prostatic Hyperplasia: Surgical Therapy and New Technology
  • Imaging/Radiology: Uroradiology
  • Prostate Cancer: Detection and Screening
  • Prostate Cancer: Markers
  • Prostate Cancer: Localized
  • Stone Disease: New Technology
  • Transplantation & Vascular Surgery: Renal Transplantation, Vascular Surgery

3:30 - 5:30 p.m.

  • Transplantation & Vascular Surgery: Renal Transplantation, Vascular Surgery
  • Prostate Cancer: Markers
  • Prostate Cancer: Detection and Screening
  • Imaging/Radiology: Uroradiology

back to top






Need assistance? Please call 1-800-908-9414 or 410-689-3917 or e-mail convention@AUAnet.org.

© 2010 American Urological Association.
All Rights Reserved.